Replying to:
We are very glad to share the recent article reporting the Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX) by Pierre Leblond ,Emmanuelle Tresch-Bruneel,Alicia Probst ,Nadège Néant,Caroline Solas ,Arthur Sterin,Thomas Boulanger,Isabelle Aerts,Cécile Faure-Conter,Anne-Isabelle Bertozzi ,Pascal Chastagner,Natacha Entz-Werlé, Emilie De Carli,Marie-Cécile Le Deley,Gauthier Bouche and Nicolas André
from (...)